An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
NCT03708965
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Mucopolysaccharidosis II
Interventions
DRUG:
JR-141
Sponsor
JCR Pharmaceuticals Co., Ltd.